FDA inspection
Baxter Healthcare (Shanghai) Co., Ltd.: FDA inspection ending Dec 3, 2024
FDA inspection 1256907 · Voluntary Action Indicated (VAI) · Shanghai
Key facts
| Inspection ID | 1256907 |
|---|---|
| Firm | Baxter Healthcare (Shanghai) Co., Ltd. |
| FEI number | 3013761146 |
| Address | No. 388 Ting Zhu Highway, Jinshan |
| City | Shanghai |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Dec 3, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data